Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19)
Int Forum Allergy Rhinol
.
2021 Dec;11(12):1685-1688.
doi: 10.1002/alr.22832.
Epub 2021 Jun 9.
Authors
Paolo Boscolo-Rizzo
1
,
Francesco Guida
1
,
Jerry Polesel
2
,
Alberto Vito Marcuzzo
1
,
Vincenzo Capriotti
3
,
Andrea D'Alessandro
1
,
Enrico Zanelli
1
,
Riccardo Marzolino
1
,
Chiara Lazzarin
1
,
Paolo Antonucci
1
,
Erica Sacchet
1
,
Margherita Tofanelli
1
,
Daniele Borsetto
4
,
Nicoletta Gardenal
1
,
Martino Pengo
5
,
Giancarlo Tirelli
1
Affiliations
1
Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.
2
Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
3
Department of Neurosciences, Section of Otolaryngology, Papa Giovanni XXIII General Hospital, Bergamo, Italy.
4
Department of ENT, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
5
Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milano, Italy.
PMID:
34109765
PMCID:
PMC9291310
DOI:
10.1002/alr.22832
No abstract available
Keywords:
COVID-19; SARS-CoV-2; chronic COVID syndrome; long COVID; long haulers.
MeSH terms
Adult
COVID-19*
Disease Progression
Humans
SARS-CoV-2